Protocol for the development and validation of a Rheumatoid Arthritis PredIction moDel using primary care health records (RAPID)
Hammond, B.; Baranskaya, A.; Adderley, N.; Zemedikun, D.; d'Elia, A.; Falahee, M.; Mallen, C.; Insch, E.; Chandan, J. S.; Nirantharakumar, K.; Snell, K.; Raza, K.
Show abstract
BackgroundRheumatoid Arthritis (RA) is a chronic rheumatological condition which causes inflammation of both the joint lining and extra-articular sites. It affects around 1% of the UK population and, if not properly treated, can lead joint damage, disability, and significant socioeconomic burden. The risk of long-term damage is reduced if treatment is started in an early disease stage with treatment in the first 3 months being associated with significantly improved clinical outcomes. However, treatment is often delayed due to long referral waits and challenges in identifying early RA in primary care. We plan to use large primary care datasets to develop and validate an RA risk prediction model for use in primary care, with the aim to provide an additional mechanism for early diagnosis and referral for treatment. MethodsWe identified candidate predictors from literature review, expert clinical opinion, and patient research partner input. Using coded primary care data held in Clinical Practice Research Datalink (CPRD) Aurum, we will use a time to event Cox proportional hazards model to develop a 1-year risk prediction model for RA. This will be validated first in CPRD GOLD and then independently in the Secure Anonymised Information Linkage dataset. We will also conduct a sensitivity analysis for the same model at 2-5-year risk, with a secondary outcome of RA and initiation of a disease modifying drug, and with the addition of laboratory test results as candidate predictors. DiscussionThe resulting risk prediction model may provide an additional mechanism to distinguish early RA in primary care and reduce treatment delays through earlier referral.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Factors influencing the outcomes of non-pharmacological interventions for managing fatigue across the lifespan of people living with musculoskeletal (MSK) conditions: a scoping review protocol 93%
- Predicting pain and function outcomes in people consulting with shoulder pain: The PANDA-S clinical cohort and qualitative study protocol (ISRCTN 46948079) 92%
- Exploring Risk Factors for Comorbid Depression in Osteoarthritis: A Scoping Review Protocol 92%
Similar papers in this journal
- Prodromal symptoms of rheumatoid arthritis in a primary care database: variation by ethnicity and socioeconomic status 96%
- A new indicator to measure discordance between patient reported outcomes and traditional disease activity holds promise to advance care trajectories improve care in patients with early Rheumatoid Arthritis 95%
- Risk of death among people with rare autoimmune diseases compared to the general population in England during the 2020 COVID-19 pandemic 95%
Similar papers in this journal
- Refractory Inflammatory Arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process 95%
- Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement – the Mobilise-D study protocol 93%
- UK osteopathic practice in 2019: a retrospective analysis of practice data 92%
Similar papers in this journal
- Versus Arthritis Musculoskeletal Disorders Research Advisory Group Priority Setting Exercise Protocol 95%
- Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY 94%
- Gout and coronavirus disease-19 (COVID-19): the risk of diagnosis and death in the UK Biobank 91%
Similar papers in this journal
- Computer vision detects inflammatory arthritis in standardized smartphone photographs in an Indian patient cohort 92%
- Relationship Between Patient Sex and Serum Tumor Necrosis Factor Antagonist Drug and Anti-Drug Antibody Concentrations in Inflammatory Bowel Disease; A Nationwide Cohort Study 91%
- Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal – a multicentre, nationwide study 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.